Literature DB >> 1812897

Activation markers on peripheral blood T cells from patients with active or inactive systemic lupus erythematosus. Correlation with proliferative responses and production of IL-2.

J Alcocer-Varela1, M Alarcón-Riquelme, A Laffón, F Sánchez-Madrid, D Alarcón-Segovia.   

Abstract

Using various monoclonal antibodies to T cell activation molecules it has been shown that purified T cells from patients with active systemic lupus erythematosus overexpress the 4F2, IL-2R (CD25), HLA-DR and T10 antigens. T cells from patients with inactive disease had increased expression of VLA-1 and HLA-DR. Increased T10 expression on T cells from patients with active disease correlated inversely with the production of IL-2, whereas expression of CD25 was slightly increased after 3-day culture with either PHA or anti-CD3. These results provide further evidence of the in vivo activation of T cells in SLE and suggest that such activation comes slowly to a halt upon disease remission.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1812897     DOI: 10.1016/0896-8411(91)90056-i

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  6 in total

1.  Expression of IL-2R, IL-4R, IL-6R on peripheral blood lymphocytes in systemic lupus erythematosus and correlation with disease activity: a prospective study.

Authors:  E Y Chan; C S Lau; H Zola
Journal:  J Clin Pathol       Date:  1996-08       Impact factor: 3.411

2.  Functional activation of lymphocyte CD44 in peripheral blood is a marker of autoimmune disease activity.

Authors:  P Estess; H C DeGrendele; V Pascual; M H Siegelman
Journal:  J Clin Invest       Date:  1998-09-15       Impact factor: 14.808

3.  Restricted junctional diversity of T cell receptor delta gene rearrangements expressed in systemic lupus erythematosus (SLE) patients.

Authors:  C Olive; P A Gatenby; S W Serjeantson
Journal:  Clin Exp Immunol       Date:  1994-09       Impact factor: 4.330

4.  Immunophenotyping reveals distinct subgroups of lupus patients based on their activated T cell subsets.

Authors:  Daniel J Perry; Anton A Titov; Eric S Sobel; Todd M Brusko; Laurence Morel
Journal:  Clin Immunol       Date:  2020-09-29       Impact factor: 3.969

5.  The CD38/NAD/SIRTUIN1/EZH2 Axis Mitigates Cytotoxic CD8 T Cell Function and Identifies Patients with SLE Prone to Infections.

Authors:  Eri Katsuyama; Abel Suarez-Fueyo; Sean J Bradley; Masayuki Mizui; Ana V Marin; Lama Mulki; Suzanne Krishfield; Fabio Malavasi; Joon Yoon; Shannan J Ho Sui; Vasileios C Kyttaris; George C Tsokos
Journal:  Cell Rep       Date:  2020-01-07       Impact factor: 9.423

6.  CD38 Correlates with an Immunosuppressive Treg Phenotype in Lupus-Prone Mice.

Authors:  Jocelyn C Pérez-Lara; Enrique Espinosa; Leopoldo Santos-Argumedo; Héctor Romero-Ramírez; Gabriela López-Herrera; Fabio García-García; Claudia Sandoval-Montes; Vianney Ortiz-Navarrete; Mónica Flores-Muñoz; Juan C Rodríguez-Alba
Journal:  Int J Mol Sci       Date:  2021-11-05       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.